Cargando…
Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial
Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and diabetes. A reduction in insulin receptor (IR) expression has been reported in these patients. The aims of this study were to evaluate the effects of a mixture of plant extracts consisting of Berberis aristata, Elaei...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950467/ https://www.ncbi.nlm.nih.gov/pubmed/31888241 http://dx.doi.org/10.3390/nu11123070 |
_version_ | 1783486078958698496 |
---|---|
author | Cossiga, Valentina Lembo, Vincenzo Guarino, Maria Tuccillo, Concetta Morando, Federica Pontillo, Giuseppina Fiorentino, Andrea Caporaso, Nicola Morisco, Filomena |
author_facet | Cossiga, Valentina Lembo, Vincenzo Guarino, Maria Tuccillo, Concetta Morando, Federica Pontillo, Giuseppina Fiorentino, Andrea Caporaso, Nicola Morisco, Filomena |
author_sort | Cossiga, Valentina |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and diabetes. A reduction in insulin receptor (IR) expression has been reported in these patients. The aims of this study were to evaluate the effects of a mixture of plant extracts consisting of Berberis aristata, Elaeis guineensis and decaffeinated green coffee by Coffea canephora on the improvement of glycaemic profile, through the modulation of IR levels, and of hepatic steatosis in NAFLD patients. Forty-nine patients with a grade of steatosis S1-S2 were randomly allocated to the treatment with plant extracts or placebo for six months. Hepatic steatosis was evaluated using transient elastography with CAP (controlled attenuation parameter). Glucose, insulin, and IR levels were measured in serum samples. At the end of the study, patients treated with plant extracts displayed a significant reduction of serum glucose (p < 0.001), insulin levels (p < 0.01), homeostatic model assessment for insulin resistance (HOMA-IR) index (p < 0.001), and CAP value (p < 0.01) compared to placebo. Moreover, the IR expression was increased significantly in the plant extracts group compared to the placebo group (p < 0.05). The combination of plant extracts increases serum IR levels, determining amelioration of glycemic profile and improvement of hepatic steatosis in NAFLD patients. |
format | Online Article Text |
id | pubmed-6950467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69504672020-01-16 Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial Cossiga, Valentina Lembo, Vincenzo Guarino, Maria Tuccillo, Concetta Morando, Federica Pontillo, Giuseppina Fiorentino, Andrea Caporaso, Nicola Morisco, Filomena Nutrients Article Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and diabetes. A reduction in insulin receptor (IR) expression has been reported in these patients. The aims of this study were to evaluate the effects of a mixture of plant extracts consisting of Berberis aristata, Elaeis guineensis and decaffeinated green coffee by Coffea canephora on the improvement of glycaemic profile, through the modulation of IR levels, and of hepatic steatosis in NAFLD patients. Forty-nine patients with a grade of steatosis S1-S2 were randomly allocated to the treatment with plant extracts or placebo for six months. Hepatic steatosis was evaluated using transient elastography with CAP (controlled attenuation parameter). Glucose, insulin, and IR levels were measured in serum samples. At the end of the study, patients treated with plant extracts displayed a significant reduction of serum glucose (p < 0.001), insulin levels (p < 0.01), homeostatic model assessment for insulin resistance (HOMA-IR) index (p < 0.001), and CAP value (p < 0.01) compared to placebo. Moreover, the IR expression was increased significantly in the plant extracts group compared to the placebo group (p < 0.05). The combination of plant extracts increases serum IR levels, determining amelioration of glycemic profile and improvement of hepatic steatosis in NAFLD patients. MDPI 2019-12-16 /pmc/articles/PMC6950467/ /pubmed/31888241 http://dx.doi.org/10.3390/nu11123070 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cossiga, Valentina Lembo, Vincenzo Guarino, Maria Tuccillo, Concetta Morando, Federica Pontillo, Giuseppina Fiorentino, Andrea Caporaso, Nicola Morisco, Filomena Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title_full | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title_fullStr | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title_full_unstemmed | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title_short | Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial |
title_sort | berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in nafld patients: a pilot clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950467/ https://www.ncbi.nlm.nih.gov/pubmed/31888241 http://dx.doi.org/10.3390/nu11123070 |
work_keys_str_mv | AT cossigavalentina berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT lembovincenzo berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT guarinomaria berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT tuccilloconcetta berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT morandofederica berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT pontillogiuseppina berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT fiorentinoandrea berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT caporasonicola berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial AT moriscofilomena berberisaristataelaeisguineensisandcoffeacanephoraextractsmodulatetheinsulinreceptorexpressionandimprovehepaticsteatosisinnafldpatientsapilotclinicaltrial |